ABOUT US
AirBiometrics Advanced Solutions SL is a start-up dedicated to research in the biomedical field. It was founded in december 2020 by a group of 5 entrepreneurs. All of them had extensive experience in various sectors, but with an important common link: the commitment to improving the quality of life of people with inflammatory bowel disease.
Currently, our goal is to develop a portable device that allows continuous monitoring of chronic diseases (such as Crohn’s disease or ulcerative colitis) in a non-invasive and non-painful way. To this end, we continue researching the development of a decentralized Point of Care device that, in a non-invasive and painless way, allows maintaining predictive and preventive control of different chronic diseases, thus improving people’s quality of life.
team
Graduate in Business Management and Administration with 20 years of experience in international business consulting.
Enrique Vicedo
CEO
- Graduate in Business Administration and Management from ICADE (Pontifical University of Comillas).
- Accredited as a counselor by the IGE.
- Extensive international career as a strategy consultant in several organizations on several continents.
- Co-founder of AirBiometrics.
- Experience in growth, diversification and internationalization processes.
Doctor in biomedicine, with numerous publications in the area of knowledge in which this project is located.
Dulce Macias
RDD
- PhD in Biomedicine and Pharmacy at the University of Valencia.
- Specialized in analyzing the role of innate immunity, especially the different macrophage phenotypes, in the mechanisms of mucosal recovery and fibrosis development in Crohn’s disease.
- Co-founder of AirBiometrics.
Biomedical engineer with extensive experience in the applicable regulations to obtain device approval.
Amparo Vanaclocha
RAD
- Biomedical engineer with a master’s degree in prosthetics and orthotics design from the Polytechnic University of Valencia.
- Extensive experience in regulation both at the European level (ISO 13485, RD2017/745, RD2017/746) and at the FDA level.
- Varied experience in the design and development of medical implants, from initial design to serial manufacturing of the device.
Double international degree in Industrial Engineering with 5 years of experience supporting companies in management.
Fernando Dolz
COO
- Engineer with a double international degree in Industrial Engineering.
- Experience as a strategy and business consultant.
- Co-founder of AirBiometrics.
- Trainer in strategic definition and implementation in different institutions, such as the CEEI of Castellón or EDEM.
Graduate in Business Management and Administration with experience in auditing firms and as financial director in different corporations.
Daniel Sardina
CFO
- Bachelor’s and Master’s Degree in ADEM from ESADE, as well as in Account Auditing and Compliance.
- Professional with more than 20 years of experience in corporate finance, controlling and management positions in international companies.
- Co-founder of AirBiometrics.
- ROAC Auditor
PhD in Biotechnology from the Politecnic University of Valencia, with extensive research experience.
Clara Bullich
Laboratory technician
- PhD in Biotechnology from the Polytechnic University of Valencia.
- Master’s degree in Neuroscience and Cognition from the University of Utrecht (Netherlands).
- Numerous publications in international peer-reviewed journals.
- She has participated in numerous national and international conferences, as well as in research projects.
ADVISORY BOARD
- Chris has worked at Palladium for 20 years, most notably in the health sector on projects with donors such as USAID, DFID and DFAT.
- Previously he held a role as Managing Director of Strategy and Corporate Development, leading Palladium’s business and performance strategy. This included identifying, analysing and capturing new business opportunities globally; as well as impact investment asset management and impact investment advisory services.
- He was part of the global leadership team, taking part in key Palladium decisions.
- Prior to this, he oversaw Palladium’s Middle East division for nine years, including serving as CEO and Board Director of the Abu Dhabi Government Farmer Service Centre for the past 4 years.
- Chris has also held senior management positions on numerous projects around the world, as well as in Australia, the United States, Zimbabwe and Papua New Guinea.
Chris has worked at Palladium for 20 years, most notably in the health sector on projects with donors such as USAID, DFID and DFAT. As CEO, he is passionate about positive impact and creating value for the company and our clients. Prior to his role as CEO, Chris was Managing Director of Strategy and Corporate Development, leading the organisation’s business and performance strategy. This included identifying, analysing and capturing new business opportunities globally; as well as impact investment asset management and impact investment advisory business services. Additionally, as part of the global leadership team, he was part of the key decision-making team at Palladium. Prior to this, he oversaw Palladium’s Middle East division for nine years, including a role as CEO and Board Director of the Abu Dhabi Government Farmers Service Centre for the past 4 years. Christopher has also held senior management positions on numerous projects around the world, as well as in Australia, the United States, Zimbabwe and Papua New Guinea.
- Professor of Pharmacology at the University of Valencia
- Since 1999-present: Principal Investigator of research projects of the “State Program for the Promotion of Scientific and Technical Research of Excellence” of the Ministry of Economy, Industry and Competitiveness.
- Since 2004 – present: Evaluator of research projects for different national agencies (ANEP, FISS)
- Since 2005 – present: Reviewer of research journals (BJP, JCC, PlosOne….)
- Since 2006 – present: Assigned member of a research group of the Network Biomedical Research Center for Liver and Digestive Diseases (CIBERehd), Ministry of Economy and Competitiveness.
- Since 2010-present: Member of a research group of excellence. Program Prometheus.
- Since 2021: Co-principal investigator
- Since 2011 – present: Member of the Joint Biomedicine Research Unit FISABIO-Hospital Dr. Peset-UV-Universitat Jaume I.
- Young Researchers Award granted by the Spanish Society of Pharmacology corresponding to 1999.
- Current line of work: basic research in inflammatory bowel disease, mechanisms of mucosal recovery and progression to fibrosis.
She is the author of more than 80 original research articles in journals indexed in the Science citation index and more than 20 book chapters.
- Professor of Pharmacology at the University of Valencia
- Graduate in Pharmacy (1989).
- PhD in Pharmacy (1993). Thesis title: Influence of afferent fibers, opioids and endotoxin on gastric acid secretion. Extraordinary PhD Award.
- Stayed as a Foundation Fellow (1996-1997) at the Center for Ulcer Research, University of California, Los Angeles, USA under the direction of Proff. Yvette Tache.
- Principal Investigator of research projects of the “State Program for the Promotion of Scientific and Technical Research of Excellence” of the Ministry of Economy, Industry and Competitiveness since 1999.
- Evaluator of research projects for different national agencies (ANEP, FISS) since 2004
- Reviewer of research journals (BJP, JCC, PlosOne…) since 2005
- Assigned member of a research group of the Network Biomedical Research Center for Liver and Digestive Diseases (CIBERehd), Ministry of Economy and Competitiveness since 2006.
- Assigned member of a research group of the Networked Biomedical Research Center for Liver and Digestive Diseases (CIBERehd), Ministry of Economy and Competitiveness since 2007.
- Member of a research group of excellence since 2010. Prometeo Program. Since 2021: Co-principal investigator
- Member of the Joint Biomedicine Research Unit FISABIO-Hospital Dr. Peset-UV-Universitat Jaume I since 2011.
- Young Researchers Award granted by the Spanish Society of Pharmacology corresponding to 1999.
- Current line of work: basic research in inflammatory bowel disease, mechanisms of mucosal recovery and progression to fibrosis.
- Author of more than 80 original research articles in journals indexed in the Science citation index and more than 20 book chapters
- Main fields of interest: basic research in inflammatory bowel disease, mechanisms of mucosal recovery and progression to fibrosis.
- Associate physician of the Digestive System Service of the La Fe University and Polytechnic Hospital in Valencia after having been a resident physician there.
- Graduated in Medicine from the Jaume I University of Castellón.
- Master’s degree in clinical medicine research at the Miguel Hernández University of Elche. Own Master’s degree in hepatology at the Cardenal Herrera University of Valencia.
- He has completed external training internships at the Ramón y Cajal University Hospital in Madrid (digestive ultrasound unit), and at the Central University Hospital of Asturias (liver cancer unit).
- He has completed 60 courses endorsed by different schools, societies and associations in the field.
- He received the Training Grant for a national external rotation in 2022
- He received the Award for the best oral communication on the upper digestive tract at the 2021 FEAD Awards for “Incidence of Opioid-Induced Esophageal Dysfunction”.
- He has presented more than 45 oral and poster communications, both in national and international conferences.
- Author and co-author of 17 publications in national and international journals.
- Member of the Valencian Society of Digestive Pathology (SVPD), the Spanish Society of Digestive Pathology (SEPD), the Spanish Association of Gastroenterology (AEG), the Spanish Association of Digestive Ultrasound (AEED), the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) and the Young Group of the AEG
- Currently an associate physician in the Digestive System Service at the La Fe University and Polytechnic Hospital in Valencia after having been a resident physician there.
- Graduated in Medicine from the Jaume I University in Castellón.
- Master’s degree in clinical medicine research at the Miguel Hernández University in Elche.
- Own Master’s degree in hepatology at the Cardenal Herrera University in Valencia.
- He has completed external training stays at the Ramón y Cajal University Hospital in Madrid, in the digestive ultrasound unit, and at the Central University Hospital in Asturias, in the hepatocarcinoma unit.
- He has completed 60 courses endorsed by various schools, societies and associations in the field, such as the Spanish Society of Digestive Endoscopy (SEED), the Spanish Association of Digestive Ultrasound (AEED), the Valencian School of Health Studies (EVES), the Spanish Society of Digestive Pathology (SEPD), the University Hospital i Policlínic la Fe, the Spanish Association of Gastroenterology (AEG), the Spanish Association for the Study of the Liver (AEEH), the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU), the Valencian Society of Digestive Pathology (SVPD) or the Universitat Jaume I (UJI).
- He is currently a member of the Valencian Society of Digestive Pathology (SVPD), the Spanish Society of Digestive Pathology (SEPD), the Spanish Association of Gastroenterology (AEG), the Spanish Association of Digestive Ultrasound (AEED), the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) and the Young Group of the AEG.
Although currently retired, Javier has held a Director position at Roche Diagnostics for more than 20 years. In addition, he has been co-director of the extraordinary Univ Complutense and Roche chair in Diagnostics and Innovation between 2005 and 2015. He has a degree in Biochemistry from the University of Barcelona, but has completed several master’s degrees (IESE Business School and ESADE, among others) from Business Management as well as Integrated Health Systems.
- Director Hospital Solutions at Roche Diagnostics between 2010 and 2018
- Co-Director of the extraordinary chair at the Univ Complutense and Roche in Diagnostics and Innovation between 2005 and 2015
- Founder and member of the Signo Foundation between 1995 and 2015.
- Commercial Director of Roche Diagnostics between 1997 and 2010.
- National Sales Director at Boehringer Manheim between 1989 and 1997.
- Graduate in Biochemistry from the University of Barcelona.
- Diploma from the IESE Business School, as well as from Cranfield University, in Business Management.
- Master in Integrated Health Systems from ESADE.
- He was part of the group of experts in the definition of the document “Laboratorio Clínico Central. Estándares y recomendaciones de calidad y seguridad” (ie. Central Clinical Laboratory. Quality and safety standards and recommendations) published by the Ministry of Health in 2013.
- Graduate in Medicine and Surgery, Faculty of Medicine from the University
of Valencia - PhD in Medicine from the University of Valencia
- Collaborating teaching professor of Medicine at the University of Valencia
Río Hortega contract for specialist doctors. - Line of work and subspecialization: Inflammatory Bowel Disease.
- Graduate in Medicine and Surgery, Faculty of Medicine at the University of Valencia
- Doctor of Medicine at the University of Valencia
- Digestive System Specialist, via MIR.
- Collaborating teaching professor of Medicine at the University of Valencia
- Rio Hortega contract for specialist doctors. Sub-specialization in IBD.
- Digestive System Specialist Physician at the University Clinical Hospital of Valencia.
- Overship at Mount Sinai Hospital in NYC under the Rio Hortega framework.
- Research: Mentee of the first SENSEII program (2016-18).
- Member of GETECCU and ECCO.
- Co-founder of YECCO.
- Active participation in different research projects.
- Clinic: Etiology, management and monitoring of IBD, perianal disease and the association with other pathologies.
- Graduate in Medicine from the Miguel Hernández University of Elche.
- Specialized in Rheumatology at La Fe University Hospital in Valencia.
- Specialized in Rheumatology and Internal Medicine, specifically in rheumatoid arthritis, autoimmune diseases, cardiovascular risk, and osteoporosis (among other treatments and conditions).
- Professor of Infectious Diseases in the CTO group.
- Graduated in Medicine from the Miguel Hernández University of Elche.
- Specialized in Rheumatology at La Fe University Hospital in Valencia.
- Has a Master’s degree in Infectious Diseases and International Health from the Miguel Hernández University of Elche and a Master’s degree in Immune-Mediated Rheumatic Diseases from the Rey Juan Carlos University.
- PhD in Cardiovascular Risk in Inflammatory Rheumatic Diseases from the San Vicente Mártir Catholic University of Valencia.
- Specialized in Rheumatology and Internal Medicine, specifically in rheumatoid arthritis, autoimmune diseases, cardiovascular risk, and osteoporosis (among other treatments and conditions).
- Professor of Infectious Diseases in the CTO group.
- Graduate in Medicine and Surgery, Faculty of Medicine, University of Valencia.
- Specialist in Dermatology and Medical-Surgical Venereology.
- Doctor of Medicine, Faculty of Medicine, University of Valencia.
Master’s Degree in Clinical Dermatology. - Master’s Degree in Oncologic Dermatology.
- Professor in the Department of Medicine, Faculty of Medicine, University of Valencia.
- Graduate in Medicine and Surgery, Faculty of Medicine, University of Valencia.
- Specialist in Dermatology and Medical-Surgical Venereology.
- Doctor of Medicine, Faculty of Medicine, University of Valencia.
Master’s Degree in Clinical Dermatology. - Master’s Degree in Oncologic Dermatology.
- Professor in the Department of Medicine, Faculty of Medicine, University of Valencia.
COLLABORATION ACKNOWLEDGEMENTS
The following collaborators participate, or have participated to some extent, in carrying out our project, thus allowing us to move forward and achieve our objectives.
We thank Dr Pilar Nos for her time and dedication to the project.
Dr. Pilar stands out for being:
- Scientific Director of the La Fe Health Research Institute
- President of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis
- Head of the Digestive Medicine Service since 2014 at the Hospital Universitari i Politècnic La Fe de Valencia.
- President of the Valencian Society of Digestive Pathology.
- Member of the Research Commission of the Health Research Institute.
- Professor at the Valencian School of Health Studies.
- Professor of the Master’s Degree in Autoimmune Diseases at the Polytechnic University of Valencia and the AEG-GETECCU master’s degree.
- Responsible at the La Fe Health Research Institute Foundation for the accredited research group (ISCIII) in Inflammatory Bowel Disease.
Additionally, we appreciate the participation of the following companies without which we could not have achieved our objectives:
Do you want to know more?
Contact us for more information